Skip to main content

Fiscal Wizard · Single-issue tearsheet

GOSS / Jun 21, 2026 Run #7549

GOSS

Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Composite verdict

F 10.5 / 100
Bearish setup · Trend Following 7 drivers · 3 gates blocking
  • Chaikin Money Flow
  • Coppock Curve
  • Accumulation/Distribution Line
Consider long put target Δ ~0.60 · ~35 DTE Bearish setup, Grade B → ITM put target

Industry rank 430th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 20 signals100% Bear
Momentum Bearish 5Mean-reversion Neutral 49

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

18.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Asset Turnover 77
Greenblatt EY 0
Gross Margin 75
Free Cash Flow Yield 0
EV/Sales 75
Revenue Growth (YoY) 0

Technicals Bearish

2.0 / 100

Bearish setup leads (Chaikin Money Flow, Coppock Curve, Accumulation/Distribution Line); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Chaikin Money Flow 9
Accumulation/Distribution Line 12
Coppock Curve 14

Risk Gates

3 blocking 5 caution

3 guards active, 20 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for GOSS.